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AnAmericanginseng(Panaxquinquefolius)extract(GE)thatcontainedaquantiﬁableamountofginsenosideswasinvestigatedfor
the potential to inhibit proliferation, aﬀect the cell cycle, inﬂuence lipid acquisition andadiponectin expression in 3T3-L1 cells. Six
ﬁngerprint ginsenosides were quantiﬁed by high performance liquid chromatography and the respective molecular weights were
conﬁrmed by LC-ESI-MS analysis. The extract contained Rg1 (347.3 ± 99.7μgg −1, dry weight), Re (8280.4 ± 792.3μgg −1), Rb1
(1585.8 ± 86.8μgg −1), Rc (32.9 ± 8μgg −1), Rb2 (62.6 ± 10.6μgg −1) and Rd (90.4 ± 3.2μgg −1). The GE had a dose-dependent
eﬀect on 3T3-L1 cell growth, the LC50 value was determined to be 40.3 ± 5μgml −1. Cell cycle analysis showed modest changes
in the cell cycle. No signiﬁcant changes observed in both G1 and G2/M phases, however there was a signiﬁcant decrease (P <
.05) in the S phase after 24 and 48 h treatment. Apoptotic cells were modest but signiﬁcantly (P < .05) increased after 48 h (3.2
± 1.0%) compared to untreated control cells (1.5 ± 0.1%). Lipid acquisition was signiﬁcantly reduced (P < .05) by 13 and 22%
when treated at concentrations of 20.2 and 40.3μgml −1 compared to untreated control cells. In relation to adiponectin activation,
western blot analysis showed that the protein expression was signiﬁcantly (P < .05) increased at concentrations tested. A quantiﬁed
GE reduced the growth of 3T3-L1 cells, down-regulated the accumulation of lipid and up-regulated the expression of adiponectin
in the 3T3-L1 adipocyte cell model.
1.Introduction
There are many natural plant compounds that have been
shown to possess bioactive properties. Many of these com-
pounds are plant secondary metabolites that function as
deterrents to herbivores [1]. Groups of natural compounds
isolated from plants such as polyphenol epigallocatechin-3-
gallate (EGCG) from tea (Camellia sinensis)[ 2], vanilloids
such as capsaicin from chili peppers (Capsaicum annuum)
[3] and water extracts from cinnamon (Cinnamomum zey-
lanicum)[ 4] have all been shown to inﬂuence the regulation
of cultured adipocytes (3T3-L1 cells). In vivo, the molecular
regulation of adipocyte is thought to be a contributing
factor to the development of the metabolic syndrome and
diabetes [5]. These disorders share a common risk factor
of obesity. Adipocytes are a metabolically active organ that
release a complex set of cytokines that contribute to the
maintenance of health or to the development of disease. The
increase in adipocyte lipid content can inﬂuence adipocyte
function such as reducing adiponectin secretion which
has been related to insulin resistance and increase risk of
diabetes [5, 6]. Reports have shown that ginseng (Panax
quinquefolius) may improve blood glucose control in normal
and diabetic subjects [7]. Animal studies also indicate that
ginsenosides, dammarane triterpenoids (Figure 1), such as
Re may improve glucose control [8]. It is unclear if an
individual ginsenoside or a group of compounds classiﬁed
into either protopanaxatriol or protopanaxadiol ginsenoside
groups[9] such as those contained in an extract or decoction
are responsible for these reported eﬀects. The literature
on the eﬀect of speciﬁc ginsenosides on the promotion
or inhibition of adipogenesis is currently unclear. In four
reported studies using speciﬁc ginsenosides to test the eﬀect
on adipogenesis in cultured adipocytes (3T3-L1 cells), two
studiesreportedaninhibitionofPPARγ,themasterregulator
of adipocyte diﬀerentiation, using ginsenosides Rh2 and
Rg3 [10, 11] and two studies reported increased expression
PPARγ and adipogenesis [12, 13]. The objective of this2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Chemical structure of dammarane-type ginsenoside
triterpenoids detected in the GE (P. quinquefolius). Regions R1–R3
consist of diﬀerent attachments of sugar moieties and refer to the
following abbreviations: Af: arabinofuranose, Ap: arabinopyranose,
G: glucopyranose, R: rhamnopyranose.
study was to study the eﬀect of a ginseng extract (GE) on
adipocyte cell growth, diﬀerentiation and lipid acquisition of
3T3-L1 cells and the inﬂuence on adiponectin expression.
These eﬀects were investigated in terms of its cytotoxic
eﬀects on preadipocyte viability, the changes in cell cycle
distribution, lipid accumulation after diﬀerentiation as well
as the expression of adiponectin in the 3T3-L1 cell line, a
model system often used to study adipocyte metabolism.
2. Methods
2.1. Study Design. The eﬀect of American GE (P. quinque-
folius) with a quantiﬁed ginsenoside proﬁle was investigated
forapropensitytoaﬀectculturedmurineﬁbroblast(3T3-L1)
cell growth, cell cycle and to inﬂuence lipid acquisition and
adiponectin protein expression in the 3T3-L1 cell line.
2.2.ExtractionofPlantMaterial. DriedAmericanginseng(P.
quinquefolius) was purchased locally, ground and reﬂuxed
with methanol (500ml) three separate times for 3h each.
The extracts were combined, ﬁltered (Whatman no. 4
paper), and the methanol removed under vacuum and re-
suspended in distilled water. The extract was then applied
to a preconditioned polymeric absorbent Amberlite XAD-4
(Sigma, St. Louis, MO, USA) column (pore diameter of 40 ˚ A,
bed volume of 100cm3,a v e r a g eﬂ o wr a t eo f1 m l m i n −1)
and was washed with distilled water [11] and ginsenosides
werethenelutedwithabsoluteethanol(500ml)aspreviously
described [14]. The ethanol was removed under vacuum,
lyophilized and is herein referred to as the GE.
2.3. High Performance Liquid Chromatography and ESI-
MS Analysis. To assess the amount of ginsenosides, a
high performance liquid chromatography (Waters Alliance
2695, Waters, Milford, MA, USA) was employed with a
quaternary gradient pump and a photodiode array (PDA)
detector (Waters 2996), controlled by Empower Pro software
(Waters). A Waters Symmetry reversed phase C-18 Column
(4.6mm × 250mm, 5μm particle size) was used and the
mobile phase consisted of distilled water (A) and acetonitrile
(B). The column temperature was 25◦C, sample injection
volume was 20μL ,aﬂ o wr a t eo f1m lm i n −1, and detection
wavelength was set at 203nm. Two solvent programs were
previously described [14], program 1 was used to separate
Rb1, Rc, Rb2 and Rd, while program 2 was used to separate
Rg1andRe.Program1solventgradientwasasfollowsattime
0min, 20% (B), and ﬂow rate of 1mlmin−1; 20min, 25.7%
(B), 0.70mlmin−1; 40min, 49% (B), 0.70mlmin−1; 50min,
100% (B), 0.70mlmin−1; 60min, 20% B, 1mlmin−1.P r o -
gram 2 was as follows 0min, 20% (B), 1mlmin−1; 45min,
22% (B), 0.70mlmin−1; 50min, 60% (B), 0.70mlmin−1;
60min, 20.0% (B), 1mlmin−1.
Ginsenoside standards (Rg1, Re, Rb1, Rb2, Rc and Rd)
were purchased from Chromadex (Santa Ana, CA, USA)
and were used to establish calibration curves. Molecular
weight determinations and conﬁrmation of ginsenosides
were measured using a Finnigan MAT (San Jose, CA, USA)
LCQ quadrupole ion trap MS with MSn capabilities in
negative mode. The ESI-MS conditions were set as follow:
ion spray voltage of 4.50kV, capillary voltage of –17V,
capillary temperature of 290◦C and were delivered to the MS
at a ﬂow rate of 0.4mlmin−1. The scanning mass spectra
were focused on the m/z range of 50–1500U.
2.4. Cell Culture. Murine ﬁbroblast cells (3T3-L1) were
obtained from ATCC (Manassas, VA, USA). The cells were
maintained in Dulbecco’s Modiﬁed Eagle’s media (DMEM)
(Sigma) and supplemented with 10% fetal bovine serum
(Sigma) and penicillin/streptomycin (100Uml−1) (GIBCO;
Invitrogen; Burlington, Canada) in a humidiﬁed atmosphere
of 5% CO2 at 37◦C. Cell cultures were maintained at a
cell concentration between 2 × 103 and 6 × 104 cellsml−1.
Cells were subcultured by total media replacement using
0.25% (w/v) trypsin-0.53mM EDTA solution (GIBCO).
Depending on the cell numbers, cells were subcultured in
every 2–3 days, and were incubated at 37◦Ci na5 %C O 2
humidiﬁed incubator. Viable cell numbers were assessed in
quadruplicate by using 0.04% trypan blue exclusion dye
(MPBiomedicals,OH,USA)viaaNeubauerhemocytometer
(Blaubrand, Germany). GE was dissolved in DMEM and was
passed through a 0.2μm ﬁlter (Millex GP, Ireland) prior to
cell treatment.
2.5. Cell Viability MTT Assay. Cell growth was assessed
using MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide] assay to establish an LC50 value
(concentration to inhibit 50% of cells). 3T3-L1 cells were
seeded at a concentration of 2.5 × 104 cells ml−1 in 96-well
plates. Controls consisted of cells, culture media without GE.Evidence-Based Complementary and Alternative Medicine 3
GE was dissolved in culture media and incubated with cells
for 72h. The media was removed and MTT (0.5 mgml−1
dissolved in DMEM) was added and incubated in the dark
for4h.Acidiﬁedsodiumdodecylsulfate(SDS)(0.01MHCL)
was added to solubilize the formazan crystal overnight as
described previously [15]. The optical density was measured
at an absorbance of 570nm and reference absorbance
of 650nm in a microplate reader (Multiskan Spectrum,
Thermo Electro Corporation, Waltham, MA, USA). Cell
viability (%) was determined as [mean (absorbance of
sample at 570nm—absorbance of reference sample at
650nm)/mean absorbance of control] × 100%.
2.6. Cell Cycle Analysis. GE was added to 3T3-L1 cells (2.5
× 104 cells ml−1) at the LC50 of 40.3μgml −1 (described
subsequently) and incubated at 37◦Ci na5 %C O 2 in a
humidiﬁed incubator for 24, 48 and 72h. Untreated cells
acted as controls at each respective time point. Media was
collected and cells were trypsinized, combined with collected
media and centrifuged (80g, 7min). The supernatant was
discarded and cells were washed twice in phosphate buﬀered
saline (PBS). Cells were ﬁxed in ice-cold 70% ethanol
a n ds t o r e do v e r n i g h ta t4 ◦C. Ethanol was removed by
centrifugation (500g, 5min) and 1ml of PBS containing
50μgml −1 propidium iodide (Sigma) and 100Uml−1 RNase
A (Applichem Inc., CT, USA) was added and incubated
for 30min in the dark at room temperature. The cell cycle
was measured using Guava PCA ﬂow cytometer CytoSoft
software (Guava Technologies Inc, Hayward, CA, USA) as
described previously [16].
2.7. Oil Red O Staining. 3T3-L1 cells were seeded in
quadruplicate at 2.5 × 104 cells ml−1 in six-well plates
and were allowed to adhere. Cells were then induced to
diﬀerentiate utilizing the following schedule of media and
hormone additions [0.5mM 1-isobutyl-3-methylxanthine
(IBMX), 1μM dexamethasone (DEX), 10μgml −1 insulin].
GE was added during the whole diﬀerentiation process in
all media preparations and controls consisted of identical
media but without the addition of the GE. GE was added at
concentrationsof20.2and40.3μgml −1.OnDay2,themedia
was replaced with initiation media (0.5mM IBMX, 1μM
DEX). On Day 4, the media was replaced with progression
media (10μgml −1 insulin). On Days 6 and 8, the media was
replaced with only GE in media. At Day 10, the media was
replaced with 10% formalin in PBS (3ml) and incubated
for 5min at room temperature. The formalin was replaced
by formaldehyde, followed by incubation for 1h at room
temperature and the cells were washed with isopropanol
(60%) and allowed to dry. Oil red O working solution was
added to each well and left to stand for 10min as described
previously [17]. Oil red O solution was removed and
cells were washed with ﬂowing deionized water. Cells were
assessedusinganOlympusBX51(U-25ND25-2)microscope
with imaging software (Center Valley, PA, USA). To quantify
the amount of lipids accumulated, oil red O stain was
eluted with 100% isopropanol and absorbance (500nm) was
measured by a spectrophotometer.
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Figure 2: MTT-dose-response relationship of a GE (P. quinque-
folius) after 72h incubation with 3T3-L1 cells assessed by an MTT
viability assay. Values are expressed as percentage of untreated
control cells (mean ± SD).
2.8. Adipocyte Viability and Western Blot Analysis. Diﬀeren-
tiated 3T3-L1 cells (described above) were lysed using the
cell lytic reagent (Sigma) and centrifuged (13200g, 15min).
The supernatants were collected for β-Actin and adiponectin
(Acrp30) western blot analysis. Protein extracts were
quantiﬁed using BSA method according to manufacturer’s
protocol (Bio-Rad Laboratories, Hercules, CA, USA) and
measured by a spectrophotometer at an absorbance of
595nm prior to western blot analysis. Polyclonal rabbit
anti-adiponectin antibody (Acrp30), polyclonal rabbit
β-Actin and secondary antibody goat anti-rabbit IgG (H+L)
horseradish peroxidase (HRP) were purchased from BST
Scientiﬁc (Singapore). The protein extract (30μg per lane)
were separated using SDS polyacrylamide gel electrophoresis
on 12% polyacrylamide gels (Mini-Protean Tetra Cell, Bio-
Rad). Upon separation, proteins were electrophoretically
transferred to nitrocellulose (NC) membranes (ClearPAGE,
C.B.S. Scientiﬁc, Del Mar, CA, USA) by a semi-dry transfer
blotter (C.B.S. Scientiﬁc). NC membranes were ﬁrst
incubated with 5% skim milk in phosphate-buﬀered saline
with 0.1% Tween-20 (TBST) solution for 1h to reduce non-
speciﬁc binding. Acrp30 and β-Actin (1:1000 dilutions)
were then added into separate NC membranes and blotted
with 5% skim milk in TBST and were gently agitated
overnight at 4◦C. NC membranes were incubated with
peroxidase-conjugated secondary antibodies (HRP) (1:10
000) for 1h, and washed three times using TBST. β-Actin
and Acrp30 band intensity were visualized using enhanced
chemiluminescence (Thermo Scientiﬁc). Protein expressions
were visualized using a Fluorchem FC2 Imaging System
(AlphaInnotech,SanLeandro,CA,USA).Proteinexpression
was quantiﬁed densitometrically using the software GelPro
32 (Media Cybernetics, Bethesda, MD, USA).
Guava ﬂow cytometer and ViaCount Reagent (Guava
Technologies) were used to assess whether the treatment had
an eﬀect on adipocyte viability. 3T3-L1 cells were seeded in
six-well plates to a ﬁnal concentration of 2.5 × 104 cells ml−1
and diﬀerentiated as described above. Controls consisted of
theidenticalmediabutwithoutGEandthetreatmentofcells
with GE was at the LC50 concentration of 40.3 ± 5μgml −1.
At Day 10, the media was removed and adherent cells were4 Evidence-Based Complementary and Alternative Medicine
Table 1: ESI-MS ion fragments of the six major ginsenosides.
Ginsenoside Empirical Molecular Ginsenoside content Main ion fragments, m/z
retention order formula weight (Da) within extract (μgg −1)[ M – H ] − Others
Rg1 C42H72O14 801.01 347.3 ± 99.7 799.4 859.3, 945.4
Re C48H82O18 947.15 8280.4 ± 792.3 945.7 1005.2, 799.6
Rb1 C54H92O23 1109.29 1585.8 ± 86.8 1107.6 1031.4, 1163.2, 1193.1
Rc C53H90O22 1079.27 32.9 ± 8.0 1077.5 329.5, 1031.3, 1149.5
Rb2 C53H90O22 1079.27 62.6 ± 10.6 1077.5 329.5, 945.5, 1005.2, 1149.5
Rd C48H82O18 947.15 90.4 ± 3.2 945.6 1005.2, 849.7, 1059.2
Table 2: Cell cycle distribution of 3T3-L1 cells treated with GE.
Phase in cell cycle Incubation period (h) Control(a) (%) GE(b) (%) P -value
Sub G1
24 1.2 ± 0.5 2.8 ± 0.5 .20
48 1.5 ± 0.1 3.2 ± 1.0 .04∗
72 1.3 ± 0.4 1.3 ± 0.8 .36
G0/G1
24 58.4 ± 5.5 58.0 ± 6.7 .73
48 65.7 ± 3.8 62.1 ± 4.1 .88
72 68.1 ± 6.3 69.7 ± 4.0 .11
S
24 11.8 ± 2.4 9.5 ± 2.2 .03∗
48 8.0 ± 1.7 7.0 ± 1.2 .03∗
72 7.0 ± 3.0 5.6 ± 1.5 .40
G2/M
24 28.7 ± 6.2 30.1 ± 4.6 .95
48 24.9 ± 2.0 27.7 ± 3.7 .53
72 23.6 ± 4.6 23.2 ± 3.0 .10
(a)Control cells consisted of untreated cells.
(b)Tested at LC50 concentration (40.3μgml −1).
∗Signiﬁcant diﬀerence from the corresponding control value.
washed with PBS. Cells were removed by trypsinization
(described earlier). Cells were mixed with the Guava Via-
Count reagent which can distinguish between viable and
non-viable cells based on the diﬀerential permeability of
two DNA ﬂuorochrome binding dyes, for 5min in 1.5ml
microcentrifuge tubes. Guava ﬂow cytometry system with
CytoSoft software that contains the ViaCount module was
used for data acquisition and viable cells were quantiﬁed.
2.9.StatisticalMethods. Datawereexpressedasmean ±stan-
dard deviation (SD) and were analysed using paired T-test to
compare control with GE. Diﬀerences were considered sig-
niﬁcant compared to control at P<. 05 . MTT assay was per-
formed with eight replicates in three separate experiments.
BothcellcycleanalysisandoilredOstainingwereperformed
in triplicates in three separate experiments. Western blot
analysis was performed with three diﬀerent cell lysates
repeated in three separate experiments on diﬀerent days.
3. Results
3.1.GinsenosideProﬁle. TheGEwasassessedforthestandard
six ﬁngerprint ginsenosides and contained Rg1 (347.3 ±
99.7μgg −1, dry weight), Re (8280.4 ± 792.3μgg −1), Rb1
(1585.8 ± 86.8μgg −1), Rc (32.9 ± 8μgg −1), Rb2 (62.6
± 10.6μgg −1) and Rd (90.4 ± 3.2μgg −1). The standards
and the individual ginsenosides detected in the extract
was further assessed using ESI-MS analysis to conﬁrm the
molecular weight of the compounds. The molecule ion and
fragments are listed in Table 1. All six ginsenosides produced
the most abundant ion as the molecule ion [M – H]−.
3.2. MTT Dose-Response and Cell Cycle Analysis. The MTT
dose–response analysis of the eﬀect of GE on the growth of
3T3-L1 cells is shown in Figure 2. The LC50 was calculated
from a plot of viability (%) against a log concentration
(graph not shown) and yielded a linear equation of y = –
104.51 × +217.85 (r2= 0.9837). The LC50 was calculated to
be 40.3 ± 5μgml −1.
Representative cell cycle histograms of GE-treated cells
for 24, 48 and 72h are shown in Figure 3 and the corre-
sponding cell cycle analysis is listed in Table 2. Generally,
GE treatment of 3T3-L1 cells produced modest changes in
the cell cycles. The percentages of cells in the S phase were
found to be signiﬁcantly (P<. 05) decreased after 24 and
48h of treatment. Sub-G1 analysis also showed a modest but
signiﬁcant increase after 48h. No signiﬁcant changes were
observed for either G1 or G2/M phases of the cell cycle.Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Representative DNA histogram of untreated cells (control) and GE-treated cells for 24, 48 and 72h. Cells were treated at the
LC50 concentration (40.3μgml −1). DNA histograms shown are representative histograms of three individual experiments, performed in
triplicates.6 Evidence-Based Complementary and Alternative Medicine
200μm
(a) Control (1.56 ± 0.41OD 500nm)
200μm
(b) Ginseng 20.2μg/mL (1.36 ± 0.48∗ OD 500nm)
200μm
(c) Ginseng 40.3μg/mL (1.21 ± 0.44∗ OD 500nm)
Figure 4: Representative morphological images of lipid uptake
in ginseng-treated 3T3-L1 cells and corresponding quantiﬁcation
of lipid stain oil red O in parenthesis. Panels (a)–(c) represent
untreated control, ginseng-treated cells at concentrations of 20.2
and 40.3μgml −1, respectively. Values are expressed as mean ± SD,
asterisks indicate a signiﬁcant diﬀerence (P<. 05) compared to
control.
3.3. Adipogenesis and Adiponectin Expression. To investigate
the eﬀect of GE on 3T3-L1 cell diﬀerentiation and corre-
sponding lipid acquisition, cells were diﬀerentiated at one
half the LC50 (20.2μgml −1) and the LC50 (40.3μgml −1)
concentrations of the undiﬀerentiated 3T3-L1 cells with
untreated cells acting as control. Cells were stained with
oil red O and eluted stain quantiﬁed (Figure 4). Morpho-
logically, the size of the adipocytes was reduced after both
treatments compared to the control. The amount of lipid
accumulation by diﬀerentiated adipocyte was signiﬁcantly
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Figure 5: The eﬀect of a GE on the expression of adiponectin
(acrp30) in 3T3-L1 adipocytes. Western blot analysis (a) was
performed as outlined in ‘Materials and methods’ section. Pro-
tein expressions were quantiﬁed densitometrically and integrated
density values were calculated as the density values of the speciﬁc
protein bands/β-actin density values and expressed as a percentage
ofthecontrol(b)andexpressedasmean ±SDofthreeindependent
experiments. (c) The viability of the diﬀerentiated 3T3-L1 at the
concentration used for western blot analysis cell. Asterisks indicate
a signiﬁcant diﬀerent (P<. 05) compared to control (Con).
(P<. 05) decreased at both concentrations tested. After
exposure to a concentration of 20.2μgml −1, the amount of
oil red O lipid stain was signiﬁcantly reduced (P<. 05) by
13% compared to the untreated control and decreased by
22% at 40.3μgml −1.
Figure 5(a) shows the representative western blots of
3T3-L1 cells which were induced to diﬀerentiate after being
treated with at 20.2 and 40.3μgml −1, with non-treated as
control. Adiponectin expression signiﬁcantly (P<. 05)
increased at both of the concentrations tested compared toEvidence-Based Complementary and Alternative Medicine 7
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Figure 6: Schematic representation of the preadipocytes, diﬀerentiating and mature adipocytes used in this study and result obtained (red
arrows). The possible implications are represented by red dotted arrows. Solid red color inside the cells represents Oil Red O stained lipids
and small blue circle represents the nucleus.
the control. The band intensities were calculated as the den-
sity values of the adiponectin protein bands/β-actin density
values and expressed as a percentageof β-actin(Figure 5(b)).
It is also noteworthy that after diﬀerentiation GE added
at the undiﬀerentiated LC50 value of 40.3μgml −1 did not
have a signiﬁcant (P<. 05) eﬀect on adipocyte viability as
measured by the ViaCount dual DNA ﬂuorochrome binding
dyes (Figure 5(c)) which can distinguish between viable and
non viable cells. A schematic representation of the results
obtained and potential implications are outlined in Figure 6.
4. Discussion
In this study, we have shown that a GE that contained a
quantiﬁed amount of ﬁngerprint ginsenosides had a dose-
dependent eﬀect on 3T3-L1 cell growth. Protopanaxatriol
type ginsenoside Re, having two glycoside attachments (C6
and C22 of the ring structure) was found to be the most
abundant in the extract. Re is typically the most abundant
ginsenosidesreportedinAmericanginseng(P.quinquefolius)
[18]. Ginsenosides Rb1, having two glycosides moieties
attached at positions C3 and C22 is the most abundance gin-
senosidesinAsianginseng(P. ginseng) andhasbeenreported
to inhibit proliferation of 3T3-L1 preadipocytes cells in a
dose dependent manner [13]. Minor ginsenosides Rg3, Rh2
andRk1whicharenottypicallyfoundinmethanolicextracts
[18] have also been shown to have an eﬀect on 3T3-L1
cell growth [10, 11, 19]. The eﬀect of GEs [14, 20], and
individual ginsenosides [9, 21]o nav a r i e t yc u l t u r e dc a n c e r
cells has been well documented and have shown to reduce
cell growth while inducing apoptotic death. A reduction
in viable cancer cells have been reported according to the
hydrophobicity of the ginsenosides with cytoxicity generally
increasing as polarity decreases [9]. An interaction with
membrane cholesterol has been suggested as a plausible site
of action of triterpenoids [1, 22] thereby causing membrane
permeation [9] and apoptosis. In this study, 3T3-L1 cells
which are murine ﬁbroblast cells did not undergo apoptosis
to a signiﬁcant extent with only a small 1.7% increase in sub-
G1 cells noted after 48h and inﬂuenced only other minor
changes on the progression of the cell cycle. However, a
reduction in cell growth was observed. A reduction in the
preadipocyte cell number may lead to an overall reduction
in adipocyte tissue mass through adipocyte hyperplasia
[23]. Preadipocytes are ﬁbroblasts that are undiﬀerentiated
adipocytes and by reducing preadipocyte cell number or
preventing diﬀerentiation may aﬀect overall lipid acquisition
[23] and potential disease risk.
3T3-L1 cells undergo cellular diﬀerentiation from
a preadipocyte to an adipocyte-like cell when exposed to
a hormonal cocktail of insulin, dexamethasone and IBMX
[24, 25]. During the course of the 10-day diﬀerentiation
period, treatment with GE signiﬁcantly reduced the lipid
adipocyteaccumulationmeasuredbyoilredOlipidstaining.
The aglycone of ginsenoside Re, protopanaxatriol has been
reported to increase lipid uptake and increase PPARγ protein
expression which is a regulator of adipocyte diﬀerentiation.
Conversely, ginsenoside Rh2, a protopanaxadiol-type gin-
senoside inhibited adipogenesis by activating AMP kinase
(5 -AMP-activated protein kinase) which is a key enzyme
involved in lipid and cellular energy regulation [10]. AMP
kinase promotes glucose uptake into skeletal muscle and
reduces hepatic glucose output non-insulin-dependently
[26]. Ginsenoside Rg3 was also reported to inhibit PPARγ8 Evidence-Based Complementary and Alternative Medicine
and activate AMP kinase [11] and attenuated the eﬀect
of rosiglitazone, a known PPARγ ligand. GE used in this
study had 38.3 ± 3.7% of the extract as ginsenoside Re
and ginsenoside Re has been shown to suppress NF-κB
activation and increase glucose uptake in 3T3-L1 cells [27].
Adiponectin expression was enhanced after GE treatment.
Adiponectin is the major adipokine secreted by adipocytes
and is recognized as a key regulator of insulin sensitivity.
Circulating levels of adiponectin are inversely correlated
to body mass index [28] and are reduced in obese and
insulin-resistant states [24, 29, 30]. Adiponectin has been
shown to activate AMP kinase and glucose utilization in
mice and muscle cells [31]. In vivo, GEs have improved
glucose tolerance in diabetic patients [7] ,b u ti ti su n c l e a r
as to the molecular mechanism, a plausible target would
be adiponectin expression. There is a need for further
research both at the cellular and clinical levels to provide
additional mechanistic evidence of the interactions between
ginsenosides and adipokine signaling.
We have shown that an American GE, containing Re as
the most abundant ginsenoside, reduced preadipocyte cell
growth, lipid accumulation and increased the expression of
adiponectin in the 3T3-L1 cell line. Further experiments are
needed to associate these eﬀects with speciﬁc ginsenosides or
combinations of these contained in extracts and to elucidate
a speciﬁc molecular mechanism.
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